MD Anderson Cancer Center Postdoctoral Fellow in Houston, Texas
The department of Cancer Systems Imaging (CSI) is one of the largest programs at The University of Texas MD Anderson Cancer Center within the Division of Diagnostic Imaging. The goal of this department and its research program is to develop new methodologies to visualize the cellular, biochemical, and genetic processes that contribute to the development and progression of cancer and to translate these discoveries into the clinic.
Dr. Charles Manning's laboratory focuses on the discovery and translation of radiopharmaceuticals for a wide variety of uses in oncology and drug development. Trainees in the Manning lab are encouraged to participate in comprehensive 'bench-to-bedside-to-bench' research programs aimed at the discovery, prioritization, translation, and early clinical implementation of novel radiopharmaceuticals ranging from diagnostics to therapeutics. Trainees in the Manning lab access exceptional facilities dedicated to radiopharmaceutical science located in the Center for Advanced Biomedical Imaging (CABI) and Cyclotron Radiochemistry Facility (CRF). In particular, the CABI/CRF infrastructure enables a seamless transition from radiopharmaceutical discovery to translation in one location.
We are seeking motivated individuals for NIH- and CPRIT-funded post-doctoral fellowship experiences in radionuclide theranostics with a radiochemistry emphasis.
Candidates will have the opportunity to develop and lead exciting, multi-disciplinary projects along the entire compendium of theranostics discovery and translation. In addition to research, training experiences will include unique education programs foundational to Theranostics, such as developmental radiochemistry, tracer adjudication and prioritization, preclinical and clinical molecular imaging, and advanced imaging physics.
The ideal candidate would have a Ph.D. in chemistry, medicinal chemistry, or radiochemistry from an accredited institution of higher learning, with an interest in developing specialized, multi-disciplinary skills in preclinical and clinical quantitative PET imaging, radiopharmaceutical translation, and theranostics.